Gapping down
In reaction to disappointing earnings/guidance: FLDM -20.6%, ( issues Q3 prelim revenue numbers of ~$22.2 mln vs. $29.3 mln Capital IQ Consensus Est; as a result of its Q3 prelim numbers, co is suspending its full year 2016 guidance), VAC -6.4%, INSY-5.2%, UN -2.7%, DRWI -2.6%, MYCC -1.2%, APU -1%, DAL -0.9%, WGO -0.7%
Select financial related names showing weakness: SAN -3.4%, RBS -3.2%, DB -2.8%, BBVA -2.2%, CS -2.1%, HSBC -1.8%
Select metals/mining stocks trading lower: BBL -4.4%, RIO -4.4%, FCX -4%, BHP -4%, X -3.9%, VALE -3.6%
Other news: APTO -18.4% (receives a response from the FDA regarding the clinical hold of its Phase 1b clinical trial of APTO-253; the hold would not be removed at this time), FLKS -17% (provides a nocturnal leg cramp regulatory and clinical update for FLX-787; Exploratory NLC study 'did not demonstrate a statistically significant difference versus placebo), TGTX -15.2% (files with FDA an amended protocol for the GENUINE Phase 3 trial, FDA agrees that Overall Response Rate data from revised GENUINE study can be used to request pre-BLA meeting ), MELI -6.1% (MercadoLibre commences a 5.5 mln share underwritten public offering of common stock by selling stockholders eBay & certain subsidiaries; MercadoLibre offers prelim Q3 results in conjunction with today's proposed secondary offering, sees revs of $220-290 mln vs $222.13 mln Capital IQ Consensus Estimate ), VOXX -5.3% (light volume in after hours -- was up nearly 50% today on earnings), HTGM -3.2% (after jumping 35% on broad companion diagnostics master agreement w/ Merck KGaA news), BABA -1.6% (Chairman Jack Ma letter to shareholders)
Analyst comments: MT -2.4% (downgraded to Neutral from Buy at Goldman), BEAV -2.9% (downgraded to Neutral from Buy at Goldman), HDP -3.5% (downgraded to Sell from Buy at Goldman), GPRO -3.8% (Piper Jaffray noted co is not selling on Amazon (12-14% of sales) right now but should be back on that channel around Halloween), DECK -5.1% (downgraded to Neutral from Positive at Susquehanna)
In reaction to disappointing earnings/guidance: FLDM -20.6%, ( issues Q3 prelim revenue numbers of ~$22.2 mln vs. $29.3 mln Capital IQ Consensus Est; as a result of its Q3 prelim numbers, co is suspending its full year 2016 guidance), VAC -6.4%, INSY-5.2%, UN -2.7%, DRWI -2.6%, MYCC -1.2%, APU -1%, DAL -0.9%, WGO -0.7%
Select financial related names showing weakness: SAN -3.4%, RBS -3.2%, DB -2.8%, BBVA -2.2%, CS -2.1%, HSBC -1.8%
Select metals/mining stocks trading lower: BBL -4.4%, RIO -4.4%, FCX -4%, BHP -4%, X -3.9%, VALE -3.6%
Other news: APTO -18.4% (receives a response from the FDA regarding the clinical hold of its Phase 1b clinical trial of APTO-253; the hold would not be removed at this time), FLKS -17% (provides a nocturnal leg cramp regulatory and clinical update for FLX-787; Exploratory NLC study 'did not demonstrate a statistically significant difference versus placebo), TGTX -15.2% (files with FDA an amended protocol for the GENUINE Phase 3 trial, FDA agrees that Overall Response Rate data from revised GENUINE study can be used to request pre-BLA meeting ), MELI -6.1% (MercadoLibre commences a 5.5 mln share underwritten public offering of common stock by selling stockholders eBay & certain subsidiaries; MercadoLibre offers prelim Q3 results in conjunction with today's proposed secondary offering, sees revs of $220-290 mln vs $222.13 mln Capital IQ Consensus Estimate ), VOXX -5.3% (light volume in after hours -- was up nearly 50% today on earnings), HTGM -3.2% (after jumping 35% on broad companion diagnostics master agreement w/ Merck KGaA news), BABA -1.6% (Chairman Jack Ma letter to shareholders)
Analyst comments: MT -2.4% (downgraded to Neutral from Buy at Goldman), BEAV -2.9% (downgraded to Neutral from Buy at Goldman), HDP -3.5% (downgraded to Sell from Buy at Goldman), GPRO -3.8% (Piper Jaffray noted co is not selling on Amazon (12-14% of sales) right now but should be back on that channel around Halloween), DECK -5.1% (downgraded to Neutral from Positive at Susquehanna)